-
41
Influence of religion and spirituality on head and neck cancer patients and their caregivers: a protocol for a scoping review
Published 2025-01-01Subjects: “…Head and neck cancers…”
Get full text
Article -
42
Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
Published 2025-01-01Subjects: “…locally advanced head and neck cancer…”
Article -
43
-
44
Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data
Published 2025-01-01Subjects: Get full text
Article -
45
The effect of insurance status on treatment modality in advanced oral cavity cancer
Published 2023-04-01Subjects: Get full text
Article -
46
Assessment of Nutritional Status in Patients with Head and Neck Cancer Before Radiotherapy: A Single-center, Cross-sectional Study
Published 2024-03-01Subjects: “…head and neck cancer…”
Get full text
Article -
47
Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial
Published 2025-03-01Subjects: “…Head and neck cancer…”
Get full text
Article -
48
Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis
Published 2019-01-01“…The role of RAD51 gene polymorphisms with the development of head and neck cancer (HNC) and esophageal cancer (EC) remains controversial. …”
Get full text
Article -
49
Delivering Volumetric Hyperthermia to Head and Neck Cancer Patient-Specific Models Using an Ultrasound Spherical Random Phased Array Transducer
Published 2024-12-01Subjects: Get full text
Article -
50
Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints
Published 2025-01-01“…The purpose of this study was to determine the personalized optimal timing of re-planning in adaptive OAR-sparing radiation therapy, considering limited re-planning resources, for patients with head and neck cancer (HNC). Materials and methods: A novel Markov decision process (MDP) model was developed to determine optimal timing of re-planning based on the patient’s expected toxicity, characterized by normal tissue complication probability (NTCP), for four toxicities. …”
Get full text
Article -
51
Intravoxel incoherent motion (IVIM) MRI-derived masseter muscle characteristics: a new diagnostic marker in head and neck cancer?
Published 2025-01-01Subjects: “…Head and neck cancer…”
Get full text
Article -
52
Risk prediction models for dysphagia after radiotherapy among patients with head and neck cancer: a systematic review and meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
53
-
54
Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
Published 2025-02-01Subjects: “…Recurrent head and neck cancer…”
Get full text
Article -
55
Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
Published 2020-05-01“…**Background:** The role of platinum rechallenge in head and neck cancer (HNC) has not yet been fully evaluated. …”
Get full text
Article -
56
-
57
-
58
Differential gene expression profile in Porphyromonas gingivalis treated human gingival keratinocytes and their role in the development of HNSCC
Published 2025-01-01Subjects: Get full text
Article -
59
-
60